Neuroprotective Effect of S-Trans, Trans-Farnesylthiosalicylic Acid via Inhibition of RAS/ERK Pathway for the Treatment of Alzheimer’s Disease

Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s233283
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Phase I Study of S-Trans, Trans-Farnesylthiosalicylic Acid (Salirasib), a Novel Oral RAS Inhibitor in Patients With Refractory Hematologic Malignancies

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2015English

Trans-Synaptic Spread of Amyloid-Β in Alzheimer’s Disease: Paths to Β-Amyloidosis

Neural Plasticity
Neurology
2017English

The Ras Inhibitor Farnesylthiosalicylic Acid as a Potential Therapy for Neurofibromatosis Type 1

Clinical Cancer Research
Cancer ResearchOncology
2006English

Trans-Dominant Inhibition of Transcription Activator LFB1

Nucleic Acids Research
Genetics
1992English

Synthesis of Novel Heterocyclic Structures via Reaction of Isocyanides With S-Trans-Enones

English

Antioxidants Rescue Mitochondrial Transport in Differentiated Alzheimer’s Disease Trans-Mitochondrial Cybrid Cells

Journal of Alzheimer's Disease
GerontologyClinical PsychologyMental HealthPsychiatryGeriatricsMedicineNeuroscience
2016English

Waveguide CP-FTMW and Millimeter Wave Spectra of S-Cis- And S-Trans-Acrylic Acid

Journal of Molecular Spectroscopy
Molecular Physics,Theoretical ChemistryAtomicSpectroscopyOpticsPhysical
2015English

Structure Confirmation of S-Trans-Trans-Farnesylcysteine in RhodotorucineAby Application of Sulfonium Salt Cleavage Reaction

Agricultural and Biological Chemistry
1979English

The Effect of Two Sphenoidotomy Approaches on the Sense of Smell: Trans-Ethmoidal Versus Trans-Sphenoethmoidal

Rhinology
MedicineOtorhinolaryngology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy